Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer

被引：0
|
作者：
Seruga, B. [1 ]
Gan, H. K. [1 ]
Knox, J. J. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Dept Med Oncol & Hematol, Div Hematol & Med Oncol, Toronto, ON, Canada
来源：
CURRENT ONCOLOGY | 2009年 / 16卷
关键词：
Sunitinib; sorafenib; temsirolimus; toxicity; side effects; management; RENAL-CELL CARCINOMA; TYROSINE KINASE INHIBITOR; CARDIAC-HYPERTROPHY; INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB; HYPOTHYROIDISM; HYPERTENSION; MANAGEMENT; SAFETY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The toxicities of new, targeted drugs may diminish their effectiveness in advanced kidney cancer if those toxicities are not recognized and properly addressed early in patient treatment. Most of the drug-related toxicities in advanced kidney cancer are manageable with supportive care, obviating a need for long interruptions, dose reductions, or permanent discontinuation of the treatment.
引用
收藏
页码：S54 / S61
页数：8
相关论文
共 50 条
  • [1] Toxicities of Targeted Therapy and Their Management in Kidney Cancer
    Di Lorenzo, Giuseppe
    Porta, Camillo
    Bellmunt, Joaquim
    Sternberg, Cora
    Kirkali, Ziya
    Staehler, Michael
    Joniau, Steven
    Montorsi, Francesco
    Buonerba, Carlo
    EUROPEAN UROLOGY, 2011, 59 (04) : 526 - 540
  • [2] Managing toxicities of targeted therapies
    Mulder, Sasja F.
    Punt, Cornelis J. A.
    EJC SUPPLEMENTS, 2007, 5 (05): : 394 - 397
  • [3] Preface to Precision Dosing of Targeted Anti-Cancer Drugs
    Rowland, Andrew
    Sorich, Michael J.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1498 - S1499
  • [4] Optimal dosing of antidepressant drugs
    Hirakawa, Hirofumi
    LANCET PSYCHIATRY, 2019, 6 (10): : 805 - 805
  • [5] Oral targeted therapies in non-small cell cancer - managing toxicities
    Alexander, Marliese
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 55 - 55
  • [6] Optimal dosing of antidepressant drugs reply
    Furukawa, Toshi A.
    Cowen, Philip J.
    Salanti, Georgia
    Leucht, Stefan
    Egger, Matthias
    Cipriani, Andrea
    LANCET PSYCHIATRY, 2019, 6 (10): : 806 - 807
  • [7] Managing Toxicities Associated With Colorectal Cancer Chemotherapy and Targeted Therapy: A New Guide for Nurses
    Grenon, Nina N.
    Chan, Jennifer
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (03) : 285 - 296
  • [8] A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines
    Hirakawa, Akihiro
    Sudo, Kazuki
    Yonemori, Kan
    Sadachi, Ryo
    Kinoshita, Fumie
    Kobayashi, Yumiko
    Okuma, Hitomi S.
    Kawachi, Asuka
    Tamura, Kenji
    Fujiwara, Yasuhiro
    Rubinstein, Larry
    Takebe, Naoko
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 803 - 809
  • [9] Understanding, recognizing, and managing toxicities of targeted anticancer therapies
    Dy, Grace K.
    Adjei, Alex A.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2013, 63 (04) : 249 - 279
  • [10] Development of molecular targeted drugs for advanced thyroid cancer in Japan
    Takami, Hiroshi
    Ito, Koichi
    Sugino, Kiminori
    ENDOCRINE JOURNAL, 2014, 61 (09) : 833 - 839
12345